Related content

Prognostic Factors of Immunotherapy in Metastatic Renal Cell Carcinoma

By Padrik Peeter  

Medical Oncology, Vol. 20, Iss. 4, 2003-12 ,pp. : 325-334

Humana Press, Inc

Access to resources Recommend Favorite

Immunotherapy and gene therapy for renal cell carcinoma - A pilot trial

By Nishisaka N.   Jones R.F.   Maini A.   Morse P.   Wang C.Y.   Haas G.P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 5, 1997-09 ,pp. : 148-153

Elsevier

Access to resources Recommend Favorite

Active Specific Immunotherapy with an Autologous Virus-modified Tumour Cell Vaccine in Human Renal Cell Carcinoma (RCC)

By Hinkel A.   de Riese W.   Alefelder J.   Laumann D.   Falkenberg F.W.   Senge T.   Hertle L.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1719-1720

Elsevier

Access to resources Recommend Favorite

Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma

By Donskov Frede   Bennedsgaard Karen   Hokland Marianne   Marcussen Niels   Fisker Rune   Madsen Hans   Fode Kirsten   Maase Hans  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 729-739

Springer Publishing Company

Access to resources Recommend Favorite

Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study

By Kobayashi Hirohito   Tanaka Yoshimasa   Yagi Junji   Osaka Yukinari   Nakazawa Hayakazu   Uchiyama Takehiko   Minato Nagahiro   Toma Hiroshi  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. : 469-476

Springer Publishing Company

Access to resources Recommend Favorite